vs
Side-by-side financial comparison of AVALON HOLDINGS CORP (AWX) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $21.5M, roughly 1.4× AVALON HOLDINGS CORP). AVALON HOLDINGS CORP runs the higher net margin — -1.7% vs -32.1%, a 30.5% gap on every dollar of revenue. On growth, AVALON HOLDINGS CORP posted the faster year-over-year revenue change (21.7% vs -4.5%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-166.0K). Over the past eight quarters, AVALON HOLDINGS CORP's revenue compounded faster (6.7% CAGR vs -0.1%).
Avalon Hill Games Inc. is a game company that publishes wargames and strategic board games. It has also published miniature wargaming rules, role-playing games and sports simulations. It is a subsidiary of Hasbro, and operates under the company's "Hasbro Gaming" division.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
AWX vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $21.5M | $31.1M |
| Net Profit | $-356.0K | $-10.0M |
| Gross Margin | 17.1% | 25.0% |
| Operating Margin | 0.4% | -9.9% |
| Net Margin | -1.7% | -32.1% |
| Revenue YoY | 21.7% | -4.5% |
| Net Profit YoY | 28.4% | -52.0% |
| EPS (diluted) | — | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.5M | — | ||
| Q3 25 | $25.7M | $31.1M | ||
| Q2 25 | $20.3M | — | ||
| Q1 25 | $16.1M | $35.2M | ||
| Q4 24 | $17.6M | $32.6M | ||
| Q3 24 | $24.2M | $24.7M | ||
| Q2 24 | $23.1M | — | ||
| Q1 24 | $18.9M | $35.7M |
| Q4 25 | $-356.0K | — | ||
| Q3 25 | $1.9M | $-10.0M | ||
| Q2 25 | $274.0K | — | ||
| Q1 25 | $-1.5M | $-14.8M | ||
| Q4 24 | $-497.0K | $-6.6M | ||
| Q3 24 | $1.8M | $-16.2M | ||
| Q2 24 | $954.0K | — | ||
| Q1 24 | $-979.0K | $15.6M |
| Q4 25 | 17.1% | — | ||
| Q3 25 | 23.7% | 25.0% | ||
| Q2 25 | 20.6% | — | ||
| Q1 25 | 14.8% | 28.0% | ||
| Q4 24 | 17.5% | 34.0% | ||
| Q3 24 | 24.6% | 21.8% | ||
| Q2 24 | 22.1% | — | ||
| Q1 24 | 16.2% | 33.3% |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 9.1% | -9.9% | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | -7.2% | -25.7% | ||
| Q4 24 | -0.8% | -6.0% | ||
| Q3 24 | 9.4% | -46.9% | ||
| Q2 24 | 6.3% | — | ||
| Q1 24 | -2.7% | -2.5% |
| Q4 25 | -1.7% | — | ||
| Q3 25 | 7.4% | -32.1% | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | -9.3% | -42.0% | ||
| Q4 24 | -2.8% | -20.2% | ||
| Q3 24 | 7.6% | -65.7% | ||
| Q2 24 | 4.1% | — | ||
| Q1 24 | -5.2% | 43.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.29 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-0.47 | ||
| Q4 24 | — | $-0.25 | ||
| Q3 24 | — | $-0.53 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $38.4M | $-10.5M |
| Total Assets | $87.4M | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | — | ||
| Q3 25 | $4.6M | $18.9M | ||
| Q2 25 | $3.7M | — | ||
| Q1 25 | $1.3M | $5.4M | ||
| Q4 24 | $2.8M | $9.5M | ||
| Q3 24 | $3.9M | — | ||
| Q2 24 | $3.8M | — | ||
| Q1 24 | $1.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $38.4M | — | ||
| Q3 25 | $38.7M | $-10.5M | ||
| Q2 25 | $36.8M | — | ||
| Q1 25 | $36.5M | $2.2M | ||
| Q4 24 | $38.0M | $15.4M | ||
| Q3 24 | $38.5M | $-3.9M | ||
| Q2 24 | $36.7M | — | ||
| Q1 24 | $35.7M | $17.7M |
| Q4 25 | $87.4M | — | ||
| Q3 25 | $90.7M | $235.2M | ||
| Q2 25 | $88.1M | — | ||
| Q1 25 | $87.6M | $237.7M | ||
| Q4 24 | $86.2M | $255.4M | ||
| Q3 24 | $89.1M | $246.8M | ||
| Q2 24 | $91.7M | — | ||
| Q1 24 | $90.6M | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $278.0K | $1.8M |
| Free Cash FlowOCF − Capex | $-166.0K | $25.0K |
| FCF MarginFCF / Revenue | -0.8% | 0.1% |
| Capex IntensityCapex / Revenue | 2.1% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $278.0K | — | ||
| Q3 25 | $1.5M | $1.8M | ||
| Q2 25 | $3.0M | — | ||
| Q1 25 | $-982.0K | $1.2M | ||
| Q4 24 | $-579.0K | $-6.1M | ||
| Q3 24 | $342.0K | $-613.0K | ||
| Q2 24 | $3.2M | — | ||
| Q1 24 | $411.0K | $-1.4M |
| Q4 25 | $-166.0K | — | ||
| Q3 25 | $852.0K | $25.0K | ||
| Q2 25 | $2.7M | — | ||
| Q1 25 | $-1.4M | $-4.3M | ||
| Q4 24 | $-1.1M | $-8.6M | ||
| Q3 24 | $-660.0K | $-4.0M | ||
| Q2 24 | $2.9M | — | ||
| Q1 24 | $56.0K | $-7.8M |
| Q4 25 | -0.8% | — | ||
| Q3 25 | 3.3% | 0.1% | ||
| Q2 25 | 13.5% | — | ||
| Q1 25 | -8.5% | -12.1% | ||
| Q4 24 | -6.4% | -26.3% | ||
| Q3 24 | -2.7% | -16.3% | ||
| Q2 24 | 12.4% | — | ||
| Q1 24 | 0.3% | -21.8% |
| Q4 25 | 2.1% | — | ||
| Q3 25 | 2.3% | 5.6% | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 2.4% | 15.5% | ||
| Q4 24 | 3.1% | 7.5% | ||
| Q3 24 | 4.1% | 13.9% | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.9% | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | 0.76× | — | ||
| Q2 25 | 11.07× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 3.35× | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AWX
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
